Hostname: page-component-7b9c58cd5d-9klzr Total loading time: 0 Render date: 2025-03-16T09:23:28.262Z Has data issue: false hasContentIssue false

Use of whole-genome sequencing to detect an outbreak of Malassezia pachydermatis infection and colonization in a neonatal intensive care unit—California, 2015–2016

Published online by Cambridge University Press:  06 May 2020

Nancy A. Chow
Affiliation:
Centers for Disease Control and Prevention, Atlanta, Georgia
Raymond Chinn*
Affiliation:
Sharp Mary Birch Hospital for Women and Newborns, San Diego, California
Alice Pong
Affiliation:
Rady Children’s Hospital, San Diego, California
Kerry Schultz
Affiliation:
Sharp Mary Birch Hospital for Women and Newborns, San Diego, California
Janice Kim
Affiliation:
California Department of Public Health, Richmond, California
Lalitha Gade
Affiliation:
Centers for Disease Control and Prevention, Atlanta, Georgia
Brendan R. Jackson
Affiliation:
Centers for Disease Control and Prevention, Atlanta, Georgia
Karlyn D. Beer
Affiliation:
Centers for Disease Control and Prevention, Atlanta, Georgia
Anastasia P. Litvintseva
Affiliation:
Centers for Disease Control and Prevention, Atlanta, Georgia
*
Author for correspondence: Raymond Chinn, E-mail: raymond.chinn@sharp.com
Rights & Permissions [Opens in a new window]

Abstract

Whole-genome sequencing confirmed the presence of a Malassezia pachydermatis outbreak among neonates in a neonatal intensive care unit. This technology supports the importance of adhering to infection prevention measures.

Type
Concise Communication
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

The yeast Malassezia pachydermatis, a common colonizer of dogs and cats, can result in healthcare-associated infections, primarily in neonates.Reference Chen, Chiu and Chi1Reference Ilahi, Hadrich and Goudjil3 The first reported outbreak of M. pachydermatis bloodstream infections (BSIs) occurred in the 1990s in a neonatal intensive care unit (NICU).Reference Welbel, McNeil and Pramanik4 A subsequent report of a BSI outbreak in another NICU implicated indirect patient-to-patient transmission via the hands of healthcare workers (HCWs) who became colonized with M. pachydermatis after contact with pet dogs.Reference Chang, Miller and Watkins5 Using the traditional molecular technique restriction fragment length polymorphism (RFLP), these authors reported identical DNA patterns among specimens from patients, HCWs, and pet dogs of HCWs.

Fluconazole is commonly used in NICUs to prevent Candida infections in very-low-birthweight preterm infants.Reference Silva-Rios, Camargos, Correa and Romanelli6 Infections with fluconazole-resistant M. pachydermatis have been reported in preterm infants receiving fluconazole prophylaxis.Reference Chen, Chiu and Chi1,Reference Al-Sweih, Ahmad, Joseph, Khan and Khan7

We investigated a suspected outbreak of M. pachydermatis to determine epidemiologic linkages, and we performed whole-genome sequencing (WGS) to assess genetic relatedness of isolates. WGS is a powerful technology that can assist in public health investigations by providing a high degree of resolution for microbial subtyping but has not been previously used to investigate an M. pachydermatis outbreak.

Methods

We examined cases of M. pachydermatis infection and colonization during December 2015–September 2016 in an 84-bed, level 3 NICU. A case was defined as isolation of M. pachydermatis from sterile sites or skin of a patient. After the second case of M. pachydermatitis was identified, infection prevention practices were reviewed with the staff to mitigate further transmission of M. pachydermatis. Clinical data were extracted from medical records.

Susceptibility testing was performed at the University of Texas Health Science Center at San Antonio. We performed WGS on case isolates and on historical M. pachydermatis isolates stored at the US Centers for Disease Control and Prevention (CDC) using the Illumina MiSeq (Illumina, San Diego, CA). Paired-end sequences that had at least 50X coverage were used for downstream analyses. Read data were aligned to an assembly generated by PacBio sequencing (PacBio, Menlo Park, CA). Single-nucleotide polymorphism (SNP) variants were identified using SAMtools and were filtered using the publicly available SNP analysis pipeline NASP to remove positions that had <10X coverage, <90% variant allele calls, or those identified by Nucmer as being within duplicated regions in the reference.Reference Sahl, Lemmer and Travis8 Phylogenetic analyses were performed on SNP matrices using MEGA, and bootstrapping was performed with 1,000 iterations.

Results

Overall, 5 cases were identified in neonates hospitalized in NICU A; the first 4 cases (cases 1–4) occurred from December 2015 to March 2016 and the last occurred in August 2016 (case 5) (Fig. 1A and Table 1). For cases 1–4, M. pachydermatis was recovered from specimens taken in NICU A. For case 5, the culture was obtained at a different hospital (NICU B) 23 days after transfer (44th day of life) from NICU A. Using National Healthcare Safety Network surveillance definitions, 2 cases were categorized as central-line–associated BSIs (cases 1 and 3): 1 patient had a secondary BSI due to necrotizing enterocolitis (case 2); 1 patient had skin colonization (case 4); and 1 patient had peritonitis, infected urinoma, and positive urine culture (case 5).

Fig. 1. (A) Outbreak timeline: Cases 1–4 were identified in neonatal intensive care unit (NICU) A and case 5 was identified in NICU B. (B) Maximum parsimony tree showing genetic relationships among Malassezia pachydermatous isolates based on whole-genome sequencing. Outbreak isolates are marked with blue circles, and isolates from historical clusters are marked with vertical lines.

Table 1. Clinical Characteristics by Case

Note. TPN, total parenteral nutrition; PICC, peripherally inserted central catheter; CLABSI, central-line–associated bloodstream infection; BSI-NEC, secondary bloodstream infection attributed to necrotizing enterocolitis (NEC); UAC, umbilical arterial catheter; UVC, umbilical venous catheter.

a Surveillance definitions per National Healthcare Safety Network (NHSN).

b Thoracotomy chest tube for pneumothorax; spontaneous intestinal perforation with repair.

c Laparotomy for gastric perforation; necrotizing enterocolitis; extended right colectomy.

d Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with diffuse MRSA and aspergillus skin infection. M. pachydermitis felt to be colonizer.

e Laparotomy for suspected necrotizing enterocolitis.

On susceptibility testing, all 5 isolates had minimum inhibitory concentration (MIC) values of ≤0.03–0.06 for amphotericin B, >8 for micafungin, and >64 for fluconazole.

All 5 patients had stayed in the same 29-bed NICU pod. Birth weights ranged from 560 to 1,010 g, with gestational ages between 23+5 and 27+5 weeks. Positive cultures were obtained between ages 5 and 44 days. All patients had central venous catheters, were exposed to broad-spectrum antibiotics, and received fluconazole prophylaxis (Table 1). Also, 4 patients received total parenteral nutrition and 3 had comorbid conditions. No patients died.

The isolation of M. pachydermatis in this NICU and the epidemiologic clustering raised concern that an outbreak was present. Consequently, the following infection prevention strategies were implemented: (1) the importance of optimal catheter insertion and maintenance practices was reinforced; (2) NICU staff were provided with education on M. pachydermitis epidemiology; (3) proper frequency and quality of hand hygiene practices were ensured; and (4) enhanced environmental cleaning was initiated. A wider point-prevalence survey for colonization in the NICU, culturing of HCWs, and environmental sampling was not performed because it was uncertain at the time whether molecular subtyping was available. However, subsequently, using WGS, CDC confirmed that an outbreak was present.

The 5 case isolates were highly related (maximum pairwise difference of 14 SNPs), whereas case isolates were not closely related to any of the 9 historical isolates (>10,000 SNPs) (Fig. 1B). Isolates from the first 4 cases were nearly identical (≤2 SNPs), and the fifth isolate differed by ≤14 SNPs. Among the historical CDC isolates, 2 clusters were detected, with ≤4 and ≤5 SNPs among them. A review of the records revealed epidemiologic links among these isolates.

Discussion

We describe an outbreak of M. pachydermatis in a NICU that was confirmed with epidemiologic clustering and high-relatedness by WGS. Although the source of the outbreak was not identified, given that all neonates stayed in the same 29-bed pod, gaps in optimal hand hygiene practices, as previous studies have shown, likely played a role. The contribution of the environment to indirect transmission remains to be determined. WGS characterizes genetic diversity among isolates at a higher resolution than traditional methods such as RFLP. Case 5 differed from the others in several ways. Whereas isolates from cases 1–4 were nearly identical (maximum pairwise difference, 2 SNPs), they differed by 12–14 SNPs from the case 5 isolate. Case 5 was identified 5 months after the case 1–4 cluster at a different hospital, suggesting a more distant relationship. However, several factors suggest that this case was related to the outbreak. First, a retrospective review of laboratory reports at NICU B did not identify additional M. pachydermatis isolates. Second, before transferring to NICU B, where the isolate was recovered, the patient had been hospitalized in NICU A in the same pod as the other patients where the patient could have become colonized. Third, the number of SNP differences (12–14 SNPs) was still very small compared with the differences with historical isolates (>10,000 SNPs) and might simply reflect the greater time between cases.

Although there are no standardized MIC cutoffs for M. pachydermatis, all isolates had elevated MICs to fluconazole. Additionally, because M. pachydermatis is a basidiomycete and has B1,6-glucan in the cell wall rather than B1,3-glucan, it is intrinsically resistant to echinocandins. Because all 5 case patients had received fluconazole prophylaxis, our findings, together with previous reports of fluconazole-resistant M. pachydermatis, should alert clinicians to the possibility of an infection with this organism in neonates receiving fluconazole prophylaxis. The susceptibility testing profile of M. pachydermatis observed to date,Reference Leong, Buttafuoco, Glatz and Bosshard9,Reference Cafarchia, Iatta, Immediato, Puttilli and Otranto10 suggests that patients with M. pachydermatis infections should be treated with amphotericin B.

In conclusion, in response to a suspected outbreak of M. pachydermatis in the NICU, we ensured adherence to infection prevention measures, implemented enhanced environmental hygiene, and reviewed the epidemiology with HCWs to mitigate further transmission. The presence of an outbreak was confirmed using WGS. We anticipate increasing use of WGS for fungal disease outbreak investigations as the technology become increasingly affordable and accessible.

Acknowledgments

The use of product names in this manuscript does not imply their endorsement by the US Department of Health and Human Services. The finding and conclusions in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

Financial support

No financial support was provided relevant to this article.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

Footnotes

PREVIOUS PRESENTATION: The data reported here were published as an abstract in Open Forum Infectious Diseases 2017;4:S176–S177.

References

Chen, IL, Chiu, NC, Chi, H, et al. Changing of bloodstream infections in a medical center neonatal intensive care unit. J Microbiol Immunol Infect 2017;50:514520.CrossRefGoogle Scholar
Lee, J, Cho, YG, Kim, DS, Choi, SI, Lee, HS. First case of catheter-related Malassezia pachydermatis fungemia in an adult. Ann Lab Med 2019;39:99101.CrossRefGoogle ScholarPubMed
Ilahi, A, Hadrich, I, Goudjil, S, et al. Molecular epidemiology of a Malassezia pachydermatis neonatal unit outbreak. Med Mycol 2018;56:6977.CrossRefGoogle ScholarPubMed
Welbel, SF, McNeil, MM, Pramanik, A, et al. Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit. Pediatr Infect Dis J 1994;13:104108.10.1097/00006454-199402000-00005CrossRefGoogle Scholar
Chang, HJ, Miller, HL, Watkins, N, et al. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers’ pet dogs. N Engl J Med 1998;338:706711.CrossRefGoogle Scholar
Silva-Rios, J, Camargos, P, Correa, L, Romanelli, R. Prophylactic regimens with fluconazole for candidiasis in neonates under 1,500 grams: a retrospective chart review of two cohorts. J Neonatal Perinatal Med 2019;12:2936.CrossRefGoogle Scholar
Al-Sweih, N, Ahmad, S, Joseph, L, Khan, S, Khan, Z. Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine. Med Mycol Case Rep 2014;5:911.CrossRefGoogle Scholar
Sahl, JW, Lemmer, D, Travis, J, et al. NASP: an accurate, rapid method for the identification of SNPs in WGS datasets that supports flexible input and output formats. Microb Genom 2016;2(8):e000074.Google ScholarPubMed
Leong, C, Buttafuoco, A, Glatz, M, Bosshard, PP. Antifungal susceptibility testing of Malassezia spp. with an optimized colorimetric broth microdilution method. J Clin Microbiol 2017;55:18831893.CrossRefGoogle ScholarPubMed
Cafarchia, C, Iatta, R, Immediato, D, Puttilli, RM, Otranto, D. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values. Med Mycol 2015;53:743748.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. (A) Outbreak timeline: Cases 1–4 were identified in neonatal intensive care unit (NICU) A and case 5 was identified in NICU B. (B) Maximum parsimony tree showing genetic relationships among Malassezia pachydermatous isolates based on whole-genome sequencing. Outbreak isolates are marked with blue circles, and isolates from historical clusters are marked with vertical lines.

Figure 1

Table 1. Clinical Characteristics by Case